{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:28:24Z","timestamp":1793212104466,"version":"4.5.0"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R01HL138510"],"award-info":[{"award-number":["1R01HL138510"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Carolyn J. & Robert J. Allison, Jr. Family Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-025-03152-6","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T07:40:21Z","timestamp":1740728421000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Complement activity and autophagy are dysregulated in the lungs of patients with nonresolvable COVID-19 requiring lung transplantation"],"prefix":"10.1186","volume":"26","author":[{"given":"Pooja","family":"Shivshankar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey L.","family":"Mueller-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksey Y.","family":"Domozhirov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhen","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Collum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Francoise","family":"Doursout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella N.","family":"LeFebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bindu","family":"Akkanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Yau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard J.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahat","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Karmouty-Quintana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"issue":"13","key":"3152_CR1","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1001\/jama.2020.17023","volume":"324","author":"JAC Sterne","year":"2020","unstructured":"Group WHOREAfC-TW, Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J, Angus DC, Annane D, Azevedo LCP, Berwanger O, et al. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA. 2020;324(13):1330\u201341.","journal-title":"JAMA"},{"issue":"5","key":"3152_CR2","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1164\/rccm.202001-0179LE","volume":"202","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2. Am J Respir Crit Care Med. 2020;202(5):756\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"3152_CR3","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/S1473-3099(20)30434-5","volume":"20","author":"L Carsana","year":"2020","unstructured":"Carsana L, Sonzogni A, Nasr A, Rossi RS, Pellegrinelli A, Zerbi P, Rech R, Colombo R, Antinori S, Corbellino M, et al. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect Dis. 2020;20(10):1135\u201340.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"3152_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.immuni.2020.06.017","volume":"53","author":"N Mangalmurti","year":"2020","unstructured":"Mangalmurti N, Hunter CA. Cytokine storms: understanding COVID-19. Immunity. 2020;53(1):19\u201325.","journal-title":"Immunity"},{"key":"3152_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102833","volume":"57","author":"C Wang","year":"2020","unstructured":"Wang C, Xie J, Zhao L, Fei X, Zhang H, Tan Y, Nie X, Zhou L, Liu Z, Ren Y, et al. Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients. EBioMedicine. 2020;57: 102833.","journal-title":"EBioMedicine"},{"key":"3152_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12950-020-00263-3","volume":"17","author":"M Jahani","year":"2020","unstructured":"Jahani M, Dokaneheifard S, Mansouri K. Hypoxia: a key feature of COVID-19 launching activation of HIF-1 and cytokine storm. J Inflamm (Lond). 2020;17:33.","journal-title":"J Inflamm (Lond)"},{"issue":"12","key":"3152_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12931","volume":"53","author":"Z Zhao","year":"2020","unstructured":"Zhao Z, Zhao Y, Zhou Y, Wang X, Zhang T, Zuo W. Single-cell analysis identified lung progenitor cells in COVID-19 patients. Cell Prolif. 2020;53(12): e12931.","journal-title":"Cell Prolif"},{"key":"3152_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104351","volume":"86","author":"SSK Jyothula","year":"2022","unstructured":"Jyothula SSK, Peters A, Liang Y, Bi W, Shivshankar P, Yau S, Garcha PS, Yuan X, Akkanti B, Collum S, et al. Fulminant lung fibrosis in non-resolvable COVID-19 requiring transplantation. EBioMedicine. 2022;86: 104351.","journal-title":"EBioMedicine"},{"issue":"1","key":"3152_CR9","doi-asserted-by":"publisher","first-page":"6319","DOI":"10.1038\/s41467-020-20139-7","volume":"11","author":"N Desai","year":"2020","unstructured":"Desai N, Neyaz A, Szabolcs A, Shih AR, Chen JH, Thapar V, Nieman LT, Solovyov A, Mehta A, Lieb DJ, et al. Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection. Nat Commun. 2020;11(1):6319.","journal-title":"Nat Commun"},{"key":"3152_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.668725","volume":"12","author":"B Alosaimi","year":"2021","unstructured":"Alosaimi B, Mubarak A, Hamed ME, Almutairi AZ, Alrashed AA, AlJuryyan A, Enani M, Alenzi FQ, Alturaiki W. Complement anaphylatoxins and inflammatory cytokines as prognostic markers for COVID-19 severity and in-hospital mortality. Front Immunol. 2021;12: 668725.","journal-title":"Front Immunol"},{"issue":"7836","key":"3152_CR11","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41586-020-2600-6","volume":"588","author":"J Carvelli","year":"2020","unstructured":"Carvelli J, Demaria O, Vely F, Batista L, Chouaki Benmansour N, Fares J, Carpentier S, Thibult ML, Morel A, Remark R, et al. Association of COVID-19 inflammation with activation of the C5a\u2013C5aR1 axis. Nature. 2020;588(7836):146\u201350.","journal-title":"Nature"},{"issue":"7","key":"3152_CR12","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1007\/s10875-021-01061-z","volume":"41","author":"ME Hamed","year":"2021","unstructured":"Hamed ME, Naeem A, Alkadi H, Alamri AA, AlYami AS, AlJuryyan A, Alturaiki W, Enani M, Al-Shouli ST, Assiri AM, et al. Elevated expression levels of lung complement anaphylatoxin, neutrophil chemoattractant chemokine IL-8, and RANTES in MERS-CoV-infected patients: predictive biomarkers for disease severity and mortality. J Clin Immunol. 2021;41(7):1607\u201320.","journal-title":"J Clin Immunol"},{"key":"3152_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.trsl.2020.11.008","volume":"231","author":"MAS Malaquias","year":"2021","unstructured":"Malaquias MAS, Gadotti AC, Motta-Junior JDS, Martins APC, Azevedo MLV, Benevides APK, Cezar-Neto P, PaninidoCarmo LA, Zeni RC, Raboni SM, et al. The role of the lectin pathway of the complement system in SARS-CoV-2 lung injury. Transl Res. 2021;231:55\u201363.","journal-title":"Transl Res"},{"issue":"2","key":"3152_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.imlet.2004.11.010","volume":"97","author":"BP Morgan","year":"2005","unstructured":"Morgan BP, Marchbank KJ, Longhi MP, Harris CL, Gallimore AM. Complement: central to innate immunity and bridging to adaptive responses. Immunol Lett. 2005;97(2):171\u20139.","journal-title":"Immunol Lett"},{"issue":"2\u20133","key":"3152_CR15","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1385\/IR:27:2-3:549","volume":"27","author":"JO Sunyer","year":"2003","unstructured":"Sunyer JO, Boshra H, Lorenzo G, Parra D, Freedman B, Bosch N. Evolution of complement as an effector system in innate and adaptive immunity. Immunol Res. 2003;27(2\u20133):549\u201364.","journal-title":"Immunol Res"},{"key":"3152_CR16","first-page":"41","volume":"266","author":"JE Volanakis","year":"2002","unstructured":"Volanakis JE. The role of complement in innate and adaptive immunity. Curr Top Microbiol Immunol. 2002;266:41\u201356.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"6388","key":"3152_CR17","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1126\/science.aao4555","volume":"360","author":"GS Ling","year":"2018","unstructured":"Ling GS, Crawford G, Buang N, Bartok I, Tian K, Thielens NM, Bally I, Harker JA, Ashton-Rickardt PG, Rutschmann S, et al. C1q restrains autoimmunity and viral infection by regulating CD8(+) T cell metabolism. Science. 2018;360(6388):558\u201363.","journal-title":"Science"},{"key":"3152_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/v15061269","author":"N Beirag","year":"2023","unstructured":"Beirag N, Varghese PM, Neto MM, Al Aiyan A, Khan HA, Qablan M, Shamji MH, Sim RB, Temperton N, Kishore U. Complement activation-independent attenuation of SARS-CoV-2 infection by C1q and C4b-binding protein. Viruses. 2023. https:\/\/doi.org\/10.3390\/v15061269.","journal-title":"Viruses"},{"issue":"1","key":"3152_CR19","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41467-023-44211-0","volume":"15","author":"BS Haslund-Gourley","year":"2024","unstructured":"Haslund-Gourley BS, Woloszczuk K, Hou J, Connors J, Cusimano G, Bell M, Taramangalam B, Fourati S, Mege N, Bernui M, et al. IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition. Nat Commun. 2024;15(1):404.","journal-title":"Nat Commun"},{"issue":"1","key":"3152_CR20","doi-asserted-by":"publisher","first-page":"L1","DOI":"10.1152\/ajplung.00395.2017","volume":"315","author":"T Okamoto","year":"2018","unstructured":"Okamoto T, Mathai SK, Hennessy CE, Hancock LA, Walts AD, Stefanski AL, Brown KK, Lynch DA, Cosgrove GP, Groshong SD, et al. The relationship between complement C3 expression and the MUC5B genotype in pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2018;315(1):L1\u201310.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"11","key":"3152_CR21","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1136\/jmg.2008.058966","volume":"45","author":"H Li","year":"2008","unstructured":"Li H, Tang NL, Chan PK, Wang CY, Hui DS, Luk C, Kwok R, Huang W, Sung JJ, Kong QP, et al. Polymorphisms in the C-type lectin genes cluster in chromosome 19 and predisposition to severe acute respiratory syndrome coronavirus (SARS-CoV) infection. J Med Genet. 2008;45(11):752\u20138.","journal-title":"J Med Genet"},{"issue":"10","key":"3152_CR22","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1086\/429631","volume":"191","author":"WK Ip","year":"2005","unstructured":"Ip WK, Chan KH, Law HK, Tso GH, Kong EK, Wong WH, To YF, Yung RW, Chow EY, Au KL, et al. Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. J Infect Dis. 2005;191(10):1697\u2013704.","journal-title":"J Infect Dis"},{"issue":"8","key":"3152_CR23","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1086\/491479","volume":"192","author":"H Zhang","year":"2005","unstructured":"Zhang H, Zhou G, Zhi L, Yang H, Zhai Y, Dong X, Zhang X, Gao X, Zhu Y, He F. Association between mannose-binding lectin gene polymorphisms and susceptibility to severe acute respiratory syndrome coronavirus infection. J Infect Dis. 2005;192(8):1355\u201361.","journal-title":"J Infect Dis"},{"issue":"19","key":"3152_CR24","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021108375","volume":"40","author":"D Hoffmann","year":"2021","unstructured":"Hoffmann D, Mereiter S, Jin OhY, Monteil V, Elder E, Zhu R, Canena D, Hain L, Laurent E, Grunwald-Gruber C, et al. Identification of lectin receptors for conserved SARS-CoV-2 glycosylation sites. EMBO J. 2021;40(19): e108375.","journal-title":"EMBO J"},{"key":"3152_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","volume":"220","author":"C Magro","year":"2020","unstructured":"Magro C, Mulvey JJ, Berlin D, Nuovo G, Salvatore S, Harp J, Baxter-Stoltzfus A, Laurence J. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Transl Res. 2020;220:1\u201313.","journal-title":"Transl Res"},{"issue":"1","key":"3152_CR26","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41392-022-01133-5","volume":"7","author":"T Gao","year":"2022","unstructured":"Gao T, Zhu L, Liu H, Zhang X, Wang T, Fu Y, Li H, Dong Q, Hu Y, Zhang Z, et al. Highly pathogenic coronavirus N protein aggravates inflammation by MASP-2-mediated lectin complement pathway overactivation. Signal Transduct Target Ther. 2022;7(1):318.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"3152_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1385\/IR:34:2:157","volume":"34","author":"J Kohl","year":"2006","unstructured":"Kohl J. The role of complement in danger sensing and transmission. Immunol Res. 2006;34(2):157\u201376.","journal-title":"Immunol Res"},{"issue":"4","key":"3152_CR28","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.4049\/jimmunol.151.4.2159","volume":"151","author":"J Tschopp","year":"1993","unstructured":"Tschopp J, Chonn A, Hertig S, French LE. Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9. J Immunol. 1993;151(4):2159\u201365.","journal-title":"J Immunol"},{"issue":"4","key":"3152_CR29","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3803\/EnM.2020.768","volume":"35","author":"SW Hong","year":"2020","unstructured":"Hong SW, Lee J, Kim MJ, Moon SJ, Kwon H, Park SE, Rhee EJ, Lee WY. Clusterin protects lipotoxicity-induced apoptosis via upregulation of autophagy in insulin-secreting cells. Endocrinol Metab (Seoul). 2020;35(4):943\u201353.","journal-title":"Endocrinol Metab (Seoul)"},{"key":"3152_CR30","doi-asserted-by":"publisher","first-page":"5775","DOI":"10.1038\/ncomms6775","volume":"5","author":"F Zhang","year":"2014","unstructured":"Zhang F, Kumano M, Beraldi E, Fazli L, Du C, Moore S, Sorensen P, Zoubeidi A, Gleave ME. Clusterin facilitates stress-induced lipidation of LC3 and autophagosome biogenesis to enhance cancer cell survival. Nat Commun. 2014;5:5775.","journal-title":"Nat Commun"},{"issue":"6","key":"3152_CR31","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1080\/15548627.2024.2309904","volume":"20","author":"PP Praharaj","year":"2024","unstructured":"Praharaj PP, Patra S, Singh A, Panigrahi DP, Lee HY, Kabir MF, Hossain MK, Patra SK, Patro BS, Patil S, et al. CLU (clusterin) and PPARGC1A\/PGC1alpha coordinately control mitophagy and mitochondrial biogenesis for oral cancer cell survival. Autophagy. 2024;20(6):1359\u201382.","journal-title":"Autophagy"},{"issue":"7","key":"3152_CR32","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.21037\/tcr-21-2853","volume":"11","author":"C Wang","year":"2022","unstructured":"Wang C, Yu S, Qian R, Chen S, Dai C, Shan X. Prognostic and immunological significance of peroxisome proliferator-activated receptor gamma in hepatocellular carcinoma based on multiple databases. Transl Cancer Res. 2022;11(7):1938\u201353.","journal-title":"Transl Cancer Res"},{"issue":"2","key":"3152_CR33","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.virol.2010.12.045","volume":"411","author":"KA Stoermer","year":"2011","unstructured":"Stoermer KA, Morrison TE. Complement and viral pathogenesis. Virology. 2011;411(2):362\u201373.","journal-title":"Virology"},{"issue":"24","key":"3152_CR34","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1016\/j.vaccine.2007.12.003","volume":"26","author":"H Stoiber","year":"2008","unstructured":"Stoiber H, Banki Z, Wilflingseder D, Dierich MP. Complement-HIV interactions during all steps of viral pathogenesis. Vaccine. 2008;26(24):3046\u201354.","journal-title":"Vaccine"},{"issue":"9","key":"3152_CR35","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1128\/JVI.78.9.4385-4388.2004","volume":"78","author":"R Cattaneo","year":"2004","unstructured":"Cattaneo R. Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens\u2019 magnet. J Virol. 2004;78(9):4385\u20138.","journal-title":"J Virol"},{"issue":"5","key":"3152_CR36","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41579-023-00995-y","volume":"22","author":"A Jassey","year":"2024","unstructured":"Jassey A, Jackson WT. Viruses and autophagy: bend, but don\u2019t break. Nat Rev Microbiol. 2024;22(5):309\u201321.","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"3152_CR37","doi-asserted-by":"publisher","first-page":"93","DOI":"10.15698\/mic2020.04.712","volume":"7","author":"C Viret","year":"2020","unstructured":"Viret C, Rozieres A, Duclaux-Loras R, Boschetti G, Nancey S, Faure M. Regulation of anti-microbial autophagy by factors of the complement system. Microb Cell. 2020;7(4):93\u2013105.","journal-title":"Microb Cell"},{"issue":"2","key":"3152_CR38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00430-019-00648-z","volume":"209","author":"P Gupta","year":"2020","unstructured":"Gupta P, Tripathy AS. Alternative pathway of complement activation has a beneficial role against Chandipura virus infection. Med Microbiol Immunol. 2020;209(2):109\u201324.","journal-title":"Med Microbiol Immunol"},{"issue":"19","key":"3152_CR39","doi-asserted-by":"publisher","first-page":"8953","DOI":"10.1128\/JVI.74.19.8953-8965.2000","volume":"74","author":"DA Suhy","year":"2000","unstructured":"Suhy DA, Giddings TH Jr, Kirkegaard K. Remodeling the endoplasmic reticulum by poliovirus infection and by individual viral proteins: an autophagy-like origin for virus-induced vesicles. J Virol. 2000;74(19):8953\u201365.","journal-title":"J Virol"},{"issue":"22","key":"3152_CR40","doi-asserted-by":"publisher","first-page":"12543","DOI":"10.1128\/JVI.00755-07","volume":"81","author":"MP Taylor","year":"2007","unstructured":"Taylor MP, Kirkegaard K. Modification of cellular autophagy protein LC3 by poliovirus. J Virol. 2007;81(22):12543\u201353.","journal-title":"J Virol"},{"issue":"4","key":"3152_CR41","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1165\/rcmb.2015-0145OC","volume":"54","author":"LJ Garcia-Morales","year":"2016","unstructured":"Garcia-Morales LJ, Chen NY, Weng T, Luo F, Davies J, Philip K, Volcik KA, Melicoff E, Amione-Guerra J, Bunge RR, et al. Altered hypoxic-adenosine axis and metabolism in Group III pulmonary hypertension. Am J Respir Cell Mol Biol. 2016;54(4):574\u201383.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3152_CR42","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/1471-2105-7-123","volume":"7","author":"HJ Motulsky","year":"2006","unstructured":"Motulsky HJ, Brown RE. Detecting outliers when fitting data with nonlinear regression - a new method based on robust nonlinear regression and the false discovery rate. BMC Bioinform. 2006;7:123.","journal-title":"BMC Bioinform"},{"issue":"3","key":"3152_CR43","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/BF00185116","volume":"35","author":"GC Sellar","year":"1992","unstructured":"Sellar GC, Cockburn D, Reid KB. Localization of the gene cluster encoding the A, B, and C chains of human C1q to 1p34.1\u20131p36.3. Immunogenetics. 1992;35(3):214\u20136.","journal-title":"Immunogenetics"},{"issue":"1\u20132","key":"3152_CR44","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0162-3109(00)80301-X","volume":"49","author":"U Kishore","year":"2000","unstructured":"Kishore U, Reid KB. C1q: structure, function, and receptors. Immunopharmacology. 2000;49(1\u20132):159\u201370.","journal-title":"Immunopharmacology"},{"issue":"4","key":"3152_CR45","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/BF00291737","volume":"78","author":"VC Nguyen","year":"1988","unstructured":"Nguyen VC, Tosi M, Gross MS, Cohen-Haguenauer O, Jegou-Foubert C, de Tand MF, Meo T, Frezal J. Assignment of the complement serine protease genes C1r and C1s to chromosome 12 region 12p13. Hum Genet. 1988;78(4):363\u20138.","journal-title":"Hum Genet"},{"issue":"1","key":"3152_CR46","first-page":"133","volume":"68","author":"A Falus","year":"1989","unstructured":"Falus A, Kramer J, Walcz E, Varga Z, Setalo J, Jobst K, Lakatos T, Meretey K. Unequal expression of complement C4A and C4B genes in rheumatoid synovial cells, human monocytoid and hepatoma-derived cell lines. Immunology. 1989;68(1):133\u20136.","journal-title":"Immunology"},{"issue":"32","key":"3152_CR47","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1038\/s41388-023-02759-7","volume":"42","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Jia D, Kwon O, Li S, Sun H, Roudier MP, Lin DW, True L, Morrissey C, Creighton CJ, et al. Androgen-regulated stromal complement component 7 (C7) suppresses prostate cancer growth. Oncogene. 2023;42(32):2428\u201338.","journal-title":"Oncogene"},{"issue":"1","key":"3152_CR48","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1046\/j.1365-2249.2000.01238.x","volume":"121","author":"H Langeggen","year":"2000","unstructured":"Langeggen H, Pausa M, Johnson E, Casarsa C, Tedesco F. The endothelium is an extrahepatic site of synthesis of the seventh component of the complement system. Clin Exp Immunol. 2000;121(1):69\u201376.","journal-title":"Clin Exp Immunol"},{"issue":"15","key":"3152_CR49","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1182\/blood-2008-03-146472","volume":"113","author":"F Bossi","year":"2009","unstructured":"Bossi F, Rizzi L, Bulla R, Debeus A, Tripodo C, Picotti P, Betto E, Macor P, Pucillo C, Wurzner R, et al. C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function. Blood. 2009;113(15):3640\u20138.","journal-title":"Blood"},{"issue":"6","key":"3152_CR50","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41579-018-0003-6","volume":"16","author":"Y Choi","year":"2018","unstructured":"Choi Y, Bowman JW, Jung JU. Autophagy during viral infection\u2014a double-edged sword. Nat Rev Microbiol. 2018;16(6):341\u201354.","journal-title":"Nat Rev Microbiol"},{"key":"3152_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.958801","volume":"13","author":"H Zhang","year":"2022","unstructured":"Zhang H, Alford T, Liu S, Zhou D, Wang J. Influenza virus causes lung immunopathology through down-regulating PPARgamma activity in macrophages. Front Immunol. 2022;13: 958801.","journal-title":"Front Immunol"},{"issue":"6","key":"3152_CR52","doi-asserted-by":"publisher","first-page":"7540","DOI":"10.1096\/fj.201902397R","volume":"34","author":"P Shivshankar","year":"2020","unstructured":"Shivshankar P, Li YD, Mueller-Ortiz SL, Wetsel RA. In response to complement anaphylatoxin peptides C3a and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells. FASEB J. 2020;34(6):7540\u201360.","journal-title":"FASEB J"},{"issue":"10","key":"3152_CR53","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.4049\/jimmunol.1900314","volume":"203","author":"SL Mueller-Ortiz","year":"2019","unstructured":"Mueller-Ortiz SL, Shivshankar P, Wetsel RA. The second receptor for C5a, C5aR2, Is detrimental to mice during systemic infection with listeria monocytogenes. J Immunol. 2019;203(10):2701\u201311.","journal-title":"J Immunol"},{"issue":"8","key":"3152_CR54","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.4049\/jimmunol.1601420","volume":"198","author":"SL Mueller-Ortiz","year":"2017","unstructured":"Mueller-Ortiz SL, Calame DG, Shenoi N, Li YD, Wetsel RA. The complement anaphylatoxins C5a and C3a suppress IFN-beta production in response to listeria monocytogenes by inhibition of the cyclic dinucleotide-activated cytosolic surveillance pathway. J Immunol. 2017;198(8):3237\u201344.","journal-title":"J Immunol"},{"issue":"1\u20132","key":"3152_CR55","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cca.2008.10.003","volume":"399","author":"K Deiteren","year":"2009","unstructured":"Deiteren K, Hendriks D, Scharpe S, Lambeir AM. Carboxypeptidase M: multiple alliances and unknown partners. Clin Chim Acta. 2009;399(1\u20132):24\u201339.","journal-title":"Clin Chim Acta"},{"issue":"24","key":"3152_CR56","doi-asserted-by":"publisher","first-page":"3966","DOI":"10.1016\/j.febslet.2009.10.036","volume":"583","author":"T Maier","year":"2009","unstructured":"Maier T, Guell M, Serrano L. Correlation of mRNA and protein in complex biological samples. FEBS Lett. 2009;583(24):3966\u201373.","journal-title":"FEBS Lett"},{"key":"3152_CR57","doi-asserted-by":"publisher","first-page":"10775","DOI":"10.1038\/srep10775","volume":"5","author":"A Koussounadis","year":"2015","unstructured":"Koussounadis A, Langdon SP, Um IH, Harrison DJ, Smith VA. Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model system. Sci Rep. 2015;5:10775.","journal-title":"Sci Rep"},{"issue":"45","key":"3152_CR58","doi-asserted-by":"publisher","first-page":"28336","DOI":"10.1073\/pnas.2018030117","volume":"117","author":"M Wu","year":"2020","unstructured":"Wu M, Chen Y, Xia H, Wang C, Tan CY, Cai X, Liu Y, Ji F, Xiong P, Liu R, et al. Transcriptional and proteomic insights into the host response in fatal COVID-19 cases. Proc Natl Acad Sci U S A. 2020;117(45):28336\u201343.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3152_CR59","doi-asserted-by":"publisher","first-page":"855","DOI":"10.15252\/msb.20156423","volume":"12","author":"Z Cheng","year":"2016","unstructured":"Cheng Z, Teo G, Krueger S, Rock TM, Koh HW, Choi H, Vogel C. Differential dynamics of the mammalian mRNA and protein expression response to misfolding stress. Mol Syst Biol. 2016;12(1):855.","journal-title":"Mol Syst Biol"},{"issue":"14","key":"3152_CR60","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.1158\/0008-5472.CAN-04-0884","volume":"64","author":"BD Anderson","year":"2004","unstructured":"Anderson BD, Nakamura T, Russell SJ, Peng KW. High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus. Cancer Res. 2004;64(14):4919\u201326.","journal-title":"Cancer Res"},{"issue":"11","key":"3152_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187778","volume":"12","author":"J Garcia-Pardo","year":"2017","unstructured":"Garcia-Pardo J, Tanco S, Diaz L, Dasgupta S, Fernandez-Recio J, Lorenzo J, Aviles FX, Fricker LD. Substrate specificity of human metallocarboxypeptidase D: comparison of the two active carboxypeptidase domains. PLoS ONE. 2017;12(11): e0187778.","journal-title":"PLoS ONE"},{"issue":"5","key":"3152_CR62","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/S0026-895X(24)12594-1","volume":"59","author":"V Hadkar","year":"2001","unstructured":"Hadkar V, Skidgel RA. Carboxypeptidase D is up-regulated in raw 264.7 macrophages and stimulates nitric oxide synthesis by cells in arginine-free medium. Mol Pharmacol. 2001;59(5):1324\u201332.","journal-title":"Mol Pharmacol"},{"issue":"12","key":"3152_CR63","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1084\/jem.188.12.2313","volume":"188","author":"D Mevorach","year":"1998","unstructured":"Mevorach D, Mascarenhas JO, Gershov D, Elkon KB. Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med. 1998;188(12):2313\u201320.","journal-title":"J Exp Med"},{"issue":"3","key":"3152_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2021.152093","volume":"226","author":"A Kisserli","year":"2021","unstructured":"Kisserli A, Schneider N, Audonnet S, Tabary T, Goury A, Cousson J, Mahmoudi R, Bani-Sadr F, Kanagaratnam L, Jolly D, et al. Acquired decrease of the C3b\/C4b receptor (CR1, CD35) and increased C4d deposits on erythrocytes from ICU COVID-19 patients. Immunobiology. 2021;226(3): 152093.","journal-title":"Immunobiology"},{"key":"3152_CR65","doi-asserted-by":"publisher","first-page":"1015128","DOI":"10.3389\/fimmu.2022.1015128","volume":"13","author":"J Ye","year":"2022","unstructured":"Ye J, Yang P, Yang Y, Xia S. Complement C1s as a diagnostic marker and therapeutic target: Progress and propective. Front Immunol. 2022;13:1015128.","journal-title":"Front Immunol"},{"issue":"6","key":"3152_CR66","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.4049\/jimmunol.138.6.1871","volume":"138","author":"MC Peitsch","year":"1987","unstructured":"Peitsch MC, Kovacsovics TJ, Tschopp J, Isliker H. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement. J Immunol. 1987;138(6):1871\u20136.","journal-title":"J Immunol"},{"issue":"6","key":"3152_CR67","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.4049\/jimmunol.138.6.1864","volume":"138","author":"TJ Kovacsovics","year":"1987","unstructured":"Kovacsovics TJ, Peitsch MC, Kress A, Isliker H. Antibody-independent activation of C1. I. Differences in the mechanism of C1 activation by nonimmune activators and by immune complexes: C1r-independent activation of C1s by cardiolipin vesicles. J Immunol. 1987;138(6):1864\u201370.","journal-title":"J Immunol"},{"issue":"5","key":"3152_CR68","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.4049\/jimmunol.176.5.2950","volume":"176","author":"FD McGrath","year":"2006","unstructured":"McGrath FD, Brouwer MC, Arlaud GJ, Daha MR, Hack CE, Roos A. Evidence that complement protein C1q interacts with C-reactive protein through its globular head region. J Immunol. 2006;176(5):2950\u20137.","journal-title":"J Immunol"},{"issue":"12","key":"3152_CR69","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1515\/cclm-2021-0694","volume":"59","author":"CL Brasen","year":"2021","unstructured":"Brasen CL, Christensen H, Olsen DA, Kahns S, Andersen RF, Madsen JB, Lassen A, Kierkegaard H, Jensen A, Sydenham TV, et al. Daily monitoring of viral load measured as SARS-CoV-2 antigen and RNA in blood, IL-6, CRP and complement C3d predicts outcome in patients hospitalized with COVID-19. Clin Chem Lab Med. 2021;59(12):1988\u201397.","journal-title":"Clin Chem Lab Med"},{"key":"3152_CR70","doi-asserted-by":"publisher","first-page":"1147871","DOI":"10.3389\/fimmu.2023.1147871","volume":"14","author":"C Agrati","year":"2023","unstructured":"Agrati C, Bartolini B, Bordoni V, Locatelli F, Capobianchi MR, Di Caro A, Castilletti C, Ippolito G. Emerging viral infections in immunocompromised patients: a great challenge to better define the role of immune response. Front Immunol. 2023;14:1147871.","journal-title":"Front Immunol"},{"issue":"51","key":"3152_CR71","doi-asserted-by":"publisher","first-page":"41811","DOI":"10.1074\/jbc.M503813200","volume":"280","author":"V Rossi","year":"2005","unstructured":"Rossi V, Teillet F, Thielens NM, Bally I, Arlaud GJ. Functional characterization of complement proteases C1s\/mannan-binding lectin-associated serine protease-2 (MASP-2) chimeras reveals the higher C4 recognition efficacy of the MASP-2 complement control protein modules. J Biol Chem. 2005;280(51):41811\u20138.","journal-title":"J Biol Chem"},{"issue":"4\u20135","key":"3152_CR72","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1078\/0171-2985-00155","volume":"205","author":"NM Thielens","year":"2002","unstructured":"Thielens NM, Tacnet-Delorme P, Arlaud GJ. Interaction of C1q and mannan-binding lectin with viruses. Immunobiology. 2002;205(4\u20135):563\u201374.","journal-title":"Immunobiology"},{"issue":"45","key":"3152_CR73","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1078\/0171-2985-00140","volume":"205","author":"P Gal","year":"2002","unstructured":"Gal P, Ambrus G, Zavodszky P. C1s, the protease messenger of C1. Structure, function and physiological significance. Immunobiology. 2002;205(45):383\u201394.","journal-title":"Immunobiology"},{"key":"3152_CR74","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3389\/fimmu.2017.00592","volume":"8","author":"J Lu","year":"2017","unstructured":"Lu J, Kishore U. C1 complex: an adaptable proteolytic module for complement and non-complement functions. Front Immunol. 2017;8:592.","journal-title":"Front Immunol"},{"issue":"3","key":"3152_CR75","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.4049\/jimmunol.1300780","volume":"191","author":"SE Degn","year":"2013","unstructured":"Degn SE, Jensen L, Olszowski T, Jensenius JC, Thiel S. Co-complexes of MASP-1 and MASP-2 associated with the soluble pattern-recognition molecules drive lectin pathway activation in a manner inhibitable by MAp44. J Immunol. 2013;191(3):1334\u201345.","journal-title":"J Immunol"},{"key":"3152_CR76","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3389\/fimmu.2020.00201","volume":"11","author":"VM Holers","year":"2020","unstructured":"Holers VM, Borodovsky A, Scheinman RI, Ho N, Ramirez JR, Dobo J, Gal P, Lindenberger J, Hansen AG, Desai D, et al. Key components of the complement lectin pathway are not only required for the development of inflammatory arthritis but also regulate the transcription of factor D. Front Immunol. 2020;11:201.","journal-title":"Front Immunol"},{"key":"3152_CR77","doi-asserted-by":"publisher","DOI":"10.1159\/000525508","author":"MP Gotz","year":"2022","unstructured":"Gotz MP, Skjoedt MO, Bayarri-Olmos R, Hansen CB, Perez-Alos L, Jarlhelt I, Benfield T, Rosbjerg A, Garred P. Lectin pathway enzyme MASP-2 and downstream complement activation in COVID-19. J Innate Immun. 2022. https:\/\/doi.org\/10.1159\/000525508.","journal-title":"J Innate Immun"},{"issue":"15","key":"3152_CR78","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1016\/j.molimm.2009.07.006","volume":"46","author":"N Rawal","year":"2009","unstructured":"Rawal N, Rajagopalan R, Salvi VP. Stringent regulation of complement lectin pathway C3\/C5 convertase by C4b-binding protein (C4BP). Mol Immunol. 2009;46(15):2902\u201310.","journal-title":"Mol Immunol"},{"key":"3152_CR79","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.3389\/fimmu.2019.01493","volume":"10","author":"B Macsik-Valent","year":"2019","unstructured":"Macsik-Valent B, Nagy K, Fazekas L, Erdei A. Complement receptor type 1 (CR1, CD35), the inhibitor of BCR-mediated human B cell activation, differentially regulates TLR7, and TLR9 Induced responses. Front Immunol. 2019;10:1493.","journal-title":"Front Immunol"},{"issue":"4","key":"3152_CR80","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nm0402-373","volume":"8","author":"M Kopf","year":"2002","unstructured":"Kopf M, Abel B, Gallimore A, Carroll M, Bachmann MF. Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection. Nat Med. 2002;8(4):373\u20138.","journal-title":"Nat Med"},{"key":"3152_CR81","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00969-18","author":"YJ Kim","year":"2018","unstructured":"Kim YJ, Kim KH, Ko EJ, Kim MC, Lee YN, Jung YJ, Lee YT, Kwon YM, Song JM, Kang SM. Complement C3 plays a key role in inducing humoral and cellular immune responses to influenza virus strain-specific hemagglutinin-based or cross-protective M2 extracellular domain-based vaccination. J Virol. 2018. https:\/\/doi.org\/10.1128\/JVI.00969-18.","journal-title":"J Virol"},{"issue":"6","key":"3152_CR82","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/j.jaci.2021.03.038","volume":"147","author":"W Posch","year":"2021","unstructured":"Posch W, Vosper J, Noureen A, Zaderer V, Witting C, Bertacchi G, Gstir R, Filipek PA, Bonn GK, Huber LA, et al. C5aR inhibition of nonimmune cells suppresses inflammation and maintains epithelial integrity in SARS-CoV-2-infected primary human airway epithelia. J Allergy Clin Immunol. 2021;147(6):2083\u201320972086.","journal-title":"J Allergy Clin Immunol"},{"key":"3152_CR83","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ebiom.2018.09.033","volume":"36","author":"A Perl","year":"2018","unstructured":"Perl A. mTOR-dependent autophagy contributes to end-organ resistance and serves as target for treatment in autoimmune disease. EBioMedicine. 2018;36:12\u20133.","journal-title":"EBioMedicine"},{"issue":"7","key":"3152_CR84","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00109-015-1297-8","volume":"93","author":"Z Yang","year":"2015","unstructured":"Yang Z, Goronzy JJ, Weyand CM. Autophagy in autoimmune disease. J Mol Med (Berl). 2015;93(7):707\u201317.","journal-title":"J Mol Med (Berl)"},{"issue":"7","key":"3152_CR85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011733","volume":"5","author":"J Van Grol","year":"2010","unstructured":"Van Grol J, Subauste C, Andrade RM, Fujinaga K, Nelson J, Subauste CS. HIV-1 inhibits autophagy in bystander macrophage\/monocytic cells through Src-Akt and STAT3. PLoS ONE. 2010;5(7): e11733.","journal-title":"PLoS ONE"},{"issue":"11","key":"3152_CR86","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1016\/j.biocel.2009.06.007","volume":"41","author":"J Zhou","year":"2009","unstructured":"Zhou J, Zhang W, Liang B, Casimiro MC, Whitaker-Menezes D, Wang M, Lisanti MP, Lanza-Jacoby S, Pestell RG, Wang C. PPARgamma activation induces autophagy in breast cancer cells. Int J Biochem Cell Biol. 2009;41(11):2334\u201342.","journal-title":"Int J Biochem Cell Biol"},{"issue":"9","key":"3152_CR87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004412","volume":"10","author":"MS Lee","year":"2014","unstructured":"Lee MS, Jones T, Song DY, Jang JH, Jung JU, Gao SJ. Exploitation of the complement system by oncogenic Kaposi\u2019s sarcoma-associated herpesvirus for cell survival and persistent infection. PLoS Pathog. 2014;10(9): e1004412.","journal-title":"PLoS Pathog"},{"issue":"4","key":"3152_CR88","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1128\/IAI.74.4.2428-2435.2006","volume":"74","author":"NJ Weyand","year":"2006","unstructured":"Weyand NJ, Lee SW, Higashi DL, Cawley D, Yoshihara P, So M. Monoclonal antibody detection of CD46 clustering beneath Neisseria gonorrhoeae microcolonies. Infect Immun. 2006;74(4):2428\u201335.","journal-title":"Infect Immun"},{"issue":"14","key":"3152_CR89","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1016\/j.molimm.2007.03.012","volume":"44","author":"MJ Feito","year":"2007","unstructured":"Feito MJ, Sanchez A, Oliver MA, Perez-Caballero D, Roriguez de Cordoba S, Alberti S, Rojo JM. Membrane cofactor protein (MCP, CD46) binding to clinical isolates of Streptococcus pyogenes: binding to M type 18 strains is independent of Emm or Enn proteins. Mol Immunol. 2007;44(14):3571\u20139.","journal-title":"Mol Immunol"},{"issue":"3","key":"3152_CR90","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00826-21","volume":"96","author":"JR Hemsath","year":"2022","unstructured":"Hemsath JR, Liaci AM, Rubin JD, Parrett BJ, Lu SC, Nguyen TV, Turner MA, Chen CY, Cupelli K, Reddy VS, et al. Ex vivo and in vivo CD46 receptor utilization by species D human adenovirus serotype 26 (HAdV26). J Virol. 2022;96(3): e0082621.","journal-title":"J Virol"},{"issue":"1","key":"3152_CR91","doi-asserted-by":"publisher","first-page":"2417868","DOI":"10.1080\/22221751.2024.2417868","volume":"13","author":"L Gebetsberger","year":"2024","unstructured":"Gebetsberger L, Malekshahi Z, Teutsch A, Tajti G, Fontaine F, Marella N, Mueller A, Prantl L, Stockinger H, Stoiber H, et al. SARS-CoV-2 hijacks host CD55, CD59 and factor H to impair antibody-dependent complement-mediated lysis. Emerg Microbes Infect. 2024;13(1):2417868.","journal-title":"Emerg Microbes Infect"},{"issue":"10427","key":"3152_CR92","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S0140-6736(23)02358-9","volume":"403","author":"A Ozen","year":"2024","unstructured":"Ozen A, Chongsrisawat V, Sefer AP, Kolukisa B, Jalbert JJ, Meagher KA, Brackin T, Feldman HB, Baris S, Karakoc-Aydiner E, et al. Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 study. Lancet. 2024;403(10427):645\u201356.","journal-title":"Lancet"},{"key":"3152_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154519","volume":"247","author":"X Ge","year":"2023","unstructured":"Ge X, Yu Z, Guo X, Li L, Ye L, Ye M, Yuan J, Zhu C, Hu W, Hou Y. Complement and complement regulatory proteins are upregulated in lungs of COVID-19 patients. Pathol Res Pract. 2023;247: 154519.","journal-title":"Pathol Res Pract"},{"issue":"4","key":"3152_CR94","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1074\/jbc.M508928200","volume":"281","author":"DE Hourcade","year":"2006","unstructured":"Hourcade DE. The role of properdin in the assembly of the alternative pathway C3 convertases of complement. J Biol Chem. 2006;281(4):2128\u201332.","journal-title":"J Biol Chem"},{"key":"3152_CR95","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.747654","volume":"12","author":"PM Varghese","year":"2021","unstructured":"Varghese PM, Mukherjee S, Al-Mohanna FA, Saleh SM, Almajhdi FN, Beirag N, Alkahtani SH, Rajkumari R, Nal Rogier B, Sim RB, et al. Human properdin released by infiltrating neutrophils can modulate influenza A virus infection. Front Immunol. 2021;12: 747654.","journal-title":"Front Immunol"},{"issue":"2","key":"3152_CR96","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1046\/j.1365-2249.1999.01057.x","volume":"118","author":"SM Linton","year":"1999","unstructured":"Linton SM, Morgan BP. Properdin deficiency and meningococcal disease\u2013identifying those most at risk. Clin Exp Immunol. 1999;118(2):189\u201391.","journal-title":"Clin Exp Immunol"},{"issue":"59","key":"3152_CR97","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1126\/sciimmunol.abh2259","volume":"6","author":"L Ma","year":"2021","unstructured":"Ma L, Sahu SK, Cano M, Kuppuswamy V, Bajwa J, McPhatter JN, Pine A, Meizlish ML, Goshua G, Chang CH, et al. Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection. Sci Immunol. 2021;6(59):2259.","journal-title":"Sci Immunol"},{"issue":"2","key":"3152_CR98","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1042\/bj2640581","volume":"264","author":"T Seya","year":"1989","unstructured":"Seya T, Atkinson JP. Functional properties of membrane cofactor protein of complement. Biochem J. 1989;264(2):581\u20138.","journal-title":"Biochem J"},{"key":"3152_CR99","doi-asserted-by":"publisher","DOI":"10.3390\/v13050824","author":"V Murugaiah","year":"2021","unstructured":"Murugaiah V, Varghese PM, Beirag N, De Cordova S, Sim RB, Kishore U. Complement proteins as soluble pattern recognition receptors for pathogenic viruses. Viruses. 2021. https:\/\/doi.org\/10.3390\/v13050824.","journal-title":"Viruses"},{"issue":"1","key":"3152_CR100","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/imr.13166","volume":"313","author":"L Lucientes-Continente","year":"2023","unstructured":"Lucientes-Continente L, Marquez-Tirado B, Goicoechea de Jorge E. The factor H protein family: the switchers of the complement alternative pathway. Immunol Rev. 2023;313(1):25\u201345.","journal-title":"Immunol Rev"},{"issue":"8","key":"3152_CR101","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202012642","volume":"12","author":"A Polycarpou","year":"2020","unstructured":"Polycarpou A, Howard M, Farrar CA, Greenlaw R, Fanelli G, Wallis R, Klavinskis LS, Sacks S. Rationale for targeting complement in COVID-19. EMBO Mol Med. 2020;12(8): e12642.","journal-title":"EMBO Mol Med"},{"issue":"12","key":"3152_CR102","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S2213-2600(22)00297-1","volume":"10","author":"APJ Vlaar","year":"2022","unstructured":"Vlaar APJ, Witzenrath M, van Paassen P, Heunks LMA, Mourvillier B, de Bruin S, Lim EHT, Brouwer MC, Tuinman PR, Saraiva JFK, et al. Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Respir Med. 2022;10(12):1137\u201346.","journal-title":"Lancet Respir Med"},{"issue":"12","key":"3152_CR103","doi-asserted-by":"publisher","first-page":"e764","DOI":"10.1016\/S2665-9913(20)30341-6","volume":"2","author":"APJ Vlaar","year":"2020","unstructured":"Vlaar APJ, de Bruin S, Busch M, Timmermans S, van Zeggeren IE, Koning R, Ter Horst L, Bulle EB, van Baarle F, van de Poll MCG, et al. Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial. Lancet Rheumatol. 2020;2(12):e764\u201373.","journal-title":"Lancet Rheumatol"},{"issue":"12","key":"3152_CR104","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1097\/CCM.0000000000005683","volume":"50","author":"J Carvelli","year":"2022","unstructured":"Carvelli J, Meziani F, Dellamonica J, Cordier PY, Allardet-Servent J, Fraisse M, Velly L, Barbar SD, Lehingue S, Guervilly C, et al. Avdoralimab (anti-C5aR1 mAb) versus placebo in patients with severe COVID-19: results from a randomized controlled trial (FOR COVID elimination [FORCE]). Crit Care Med. 2022;50(12):1788\u201398.","journal-title":"Crit Care Med"}],"updated-by":[{"DOI":"10.1186\/s12931-025-03258-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000}}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03152-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-025-03152-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03152-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T02:03:09Z","timestamp":1748224989000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-025-03152-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":104,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3152"],"URL":"https:\/\/doi.org\/10.1186\/s12931-025-03152-6","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"assertion":[{"value":"16 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: The funding statement has been updated and significance levels included for all figures","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12931-025-03258-x","URL":"https:\/\/doi.org\/10.1186\/s12931-025-03258-x","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Study protocols for analyzing deidentified human specimens were approved and waiver of consent was granted by the Institutional Review Board of UTHealth Houston Committee for Protection of Human Subjects and research was performed in accordance to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"68"}}